Samstag, 23. Juni 2018


  • Pressemitteilung BoxID 336623

4SC to host conference call on 9 August 2012 to present Q2 2012 results

Planegg-Martinsried, (lifePR) - 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will announce results of the 4SC Group for the second quarter of 2012 and publish the Company's half year report 2012 on 9 August 2012. On this day the Management Board of 4SC will host a conference call at 3pm CEST (9am EDT) to inform about the consolidated financial statements in the reporting period and provide further details on the Company's latest developments.

Participants can access the conference call under the following telephone numbers:

Date: 9 August 2012
Time: 3pm CEST (9am EDT)
Dial-in numbers:
+49-6103-485-3000 (Germany)
+44-207-153-2027 (UK)
+1-480-629-9870 (USA)
+49-6103-485-3000 (other countries)
Conference-ID: 4557873

Approximately two hours after the start of the live presentation, an audio replay will be available at 4SC's website www.4sc.com in the section "Investors / Events & Presentations / Conference calls & Webcasts".

Legal Note

This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forward-looking statement subject to risks and uncertainties, many of which are beyond our control. Actual results could differ materially, depending on a number of factors.

4SC AG

The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various autoimmune and cancer indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company's balanced pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with leading pharmaceutical companies. Founded in 1997, 4SC had 90 employees at 31 March 2012. 4SC AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005.

Diese Pressemitteilungen könnten Sie auch interessieren

25 Jahre im Dienst für das Feriendorf Groß Väter See

, Medien & Kommunikation, Investor Center Uckermark GmbH Regionalmarken Management

Am Donnerstag, den 28.06.2018 wird von 10.30 bis 11.30 Uhr nach über 25-jähriger Dienstzeit die Reservierungsleiteri­n des Feriendorfs Groß Väter...

Elastischer Ärger, Riesenwut auf Nina und ein unerhörter Tausch sowie das Experiment Liebe - Fünf E-Books von Freitag bis Freitag zum Sonderpreis

, Medien & Kommunikation, EDITION digital Pekrul & Sohn GbR

Wie gehen Menschen miteinander um? Wie gehen Männer mit Frauen um – und umgekehrt? Und was ist eigentlich Liebe? Ein Experiment mit ungewissem...

Kinoprogrammpreise der nordmedia

, Medien & Kommunikation, nordmedia - Film- und Mediengesellschaft Niedersachsen/Bremen mbH

57 gewerbliche und nichtgewerbliche Filmtheater und Spielstellen aus Niedersachsen und Bremen sind am 21. Juni 2018 mit einem Kinopro-grammpreis...

Disclaimer